SCHOTT has appointed Chris Cassidy president of SCHOTT North America. Cassidy will retain his role as president of SCHOTT’s Pharma USA. He joined SCHOTT North America in 2014 as vice president of the business unit Pharmaceutical Systems.

SCHOTT has appointed Chris Cassidy president of SCHOTT North America. Cassidy will retain his role as president of SCHOTT’s Pharma USA.

SCHOTT states that Cassidy’s appointment allows it to increase its “presence in the region and focus on long-term growth.”

“The U.S. continues to be one of our most important markets,” says Dr. Heinz Kaiser, a SCHOTT board member. “With Chris as our new North America president, SCHOTT has an opportunity to drive long-term growth in this key region.”

Cassidy will be responsible for overseeing SCHOTT’s growth throughout North America. The company currently has six production sites, one research and development center and a North American corporate office in the U.S.

“From the NASA moon landing over 50 years ago to the recent nuclear fusion developments at Lawrence Livermore National Laboratory, our team continues to provide cutting-edge solutions for various industries in the U.S.,” says Cassidy. “We look forward to pursuing new opportunities that will benefit our customers now and in the future.”